pubrio
Exelixis logo

Exelixis

Public
exelixis.com
生物技术研究1,500+ employeesFounded 1994🇺🇸 美国

Every Exelixis employee is united in an ambitious cause: to transform science into new treatments that give cancer patients and their families hope for the future. In this pursuit, we know our employees are our most valuable asset. As a diverse, growing team, everyone at Exelixis plays a role in advancing our mission through our innovative drug discovery, development and commercialization efforts. We take pride in our shared purpose, knowing the magnitude of our impact expands with every medicine we create and every form of cancer tumor type we treat. After operating in the challenging biotech sector for nearly three decades, we've evolved into a multi-platform cancer company with a proven track record of resiliency in the face of adversity. The success of our flagship commercial product set us up on our journey to discover and develop next-generation cancer treatments, driven by our relentless pursuit of results for the patients we serve. Cancer is our cause. Make it yours, too. Please see our Community Guidelines: bit.ly/4iBzJU0 For more information about Exelixis, please visit www.exelixis.com, follow @ExelixisInc on Twitter or like Exelixis, Inc. on Facebook.

成立年份
1994
员工人数
1,500+
行业
生物技术研究
公司类型
Public Company
股票
nasdaq: EXEL
总部
🇺🇸Alameda, California
专长
研究行业制药行业生物技术医疗保健生物技术研究
1 / 1
活跃市场
1
新市场
IN
置信度
多为早期信号
-100%
势头
较上一周期
31 / 100
扩张评分
发展中
阶段1投入中
1 个信号 · 最近 90 天

全球扩张

实时
IN
阶段
探索中投入中进入中运营中

活动脉搏

最近 90 天内有 1 个信号。

最近 90 天
招聘
1已结束
高管变动
营销与公关
0
无活动
产品与技术
0
无活动
+2个类别已锁定
已显示 5 个中的 3 个

市场进入时间线

该公司进入各个市场的顺序 — 从最早到最新

1
🇮🇳IN进入的第 1st 个市场 · 2026推进中
投入中
1 个信号投入中 阶段
当前阶段投入中投入资源
置信度25%
开始追踪于2026首个信号

近期信号

高管变动🇮🇳 IN2个月前

Director

注册以查看完整信号动态

了解一下

关于 Exelixis 的常见问题

关于 Exelixis 的业务、市场和增长信号的快速解答。

Every Exelixis employee is united in an ambitious cause: to transform science into new treatments that give cancer patients and their families hope for the future. In this pursuit, we know our employees are our most valuable asset. As a diverse, growing team, everyone at Exelixis plays a role in advancing our mission through our innovative drug discovery, development and commercialization efforts. We take pride in our shared purpose, knowing the magnitude of our impact expands with every medicine we create and every form of cancer tumor type we treat. After operating in the challenging biotech sector for nearly three decades, we've evolved into a multi-platform cancer company with a proven track record of resiliency in the face of adversity. The success of our flagship commercial product set us up on our journey to discover and develop next-generation cancer treatments, driven by our relentless pursuit of results for the patients we serve. Cancer is our cause. Make it yours, too. Please see our Community Guidelines: bit.ly/4iBzJU0 For more information about Exelixis, please visit www.exelixis.com, follow @ExelixisInc on Twitter or like Exelixis, Inc. on Facebook.

今天就开启旅程

可以先用平台,也可以先聊聊

你可以自行使用 Pubrio,或让我们的团队协助研究、获客或数据整合。

与团队沟通
Start Journey Image
pubrio

Pubrio 将来自 50+ 本地来源的商业、人物与意向数据整合为全球图谱,帮助 AI 与营收团队洞悉全市场。

© 2026 Pubrio。保留所有权利。